RPC

Thursday 3/26 Insider Buying Report: RPC, TPST

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

At Ridgepost Capital, a filing with the SEC revealed that on Monday, Director David M. McCoy purchased 70,000 shares of RPC, at a cost of $7.37 each, for a total investment of $515,900. Ridgepost Capital is trading up about 3.1% on the day Thursday.

And on Tuesday, CEO and President Matthew Angel bought $500,001 worth of Tempest Therapeutics, buying 231,482 shares at a cost of $2.16 each. Tempest Therapeutics is trading down about 4.6% on the day Thursday. Investors can bag TPST at a price even lower than Angel did, with shares trading as low as $1.65 in trading on Thursday which is 23.8% under Angel's purchase price.

Thursday 3/26 Insider Buying Report: RPC, TPSTVIDEO: Thursday 3/26 Insider Buying Report: RPC, TPST

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.